Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Increased risk of postoperative in-hospital complications after radical prostatectomy in patients with prior organ transplant

M. Wenzel, C. Würnschimmel, F. Chierigo, Z. Tian, SF. Shariat, C. Terrone, F. Saad, D. Tilki, M. Graefen, S. Banek, LA. Kluth, P. Mandel, FKH. Chun, PI. Karakiewicz

. 2021 ; 81 (16) : 1294-1302. [pub] 20210913

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc22011863

BACKGROUND: To analyze postoperative, in-hospital, complication rates in patients with organ transplantation before radical prostatectomy (RP). METHODS: From National Inpatient Sample (NIS) database (2000-2015) prostate cancer patients treated with RP were abstracted and stratified according to prior organ transplant versus nontransplant. Multivariable logistic regression models predicted in-hospital complications. RESULTS: Of all eligible 202,419 RP patients, 216 (0.1%) underwent RP after prior organ transplantation. Transplant RP patients exhibited higher proportions of Charlson comorbidity index ≥2 (13.0% vs. 3.0%), obesity (9.3% vs. 5.6%, both p < 0.05), versus to nontransplant RP. Of transplant RP patients, 96 underwent kidney (44.4%), 44 heart (20.4%), 40 liver (18.5%), 30 (13.9%) bone marrow, <11 lung (<5%), and <11 pancreatic (<5%) transplantation before RP. Within transplant RP patients, rates of lymph node dissection ranged from 37.5% (kidney transplant) to 60.0% (bone marrow transplant, p < 0.01) versus 51% in nontransplant patients. Regarding in-hospital complications, transplant patients more frequently exhibited, diabetic (31.5% vs. 11.6%, p < 0.001), major (7.9% vs. 2.9%) cardiac complications (3.2% vs. 1.2%, p = 0.01), and acute kidney failure (5.1% vs. 0.9%, p < 0.001), versus nontransplant RP. In multivariable logistic regression models, transplant RP patients were at higher risk of acute kidney failure (odds ratio [OR]: 4.83), diabetic (OR: 2.81), major (OR: 2.39), intraoperative (OR: 2.38), cardiac (OR: 2.16), transfusion (OR: 1.37), and overall complications (1.36, all p < 0.001). No in-hospital mortalities were recorded in transplant patients after RP. CONCLUSIONS: Of all transplants before RP, kidney ranks first. RP patients with prior transplantation have an increased risk of in-hospital complications. The highest risk, relative to nontransplant RP patients appears to acute kidney failure.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22011863
003      
CZ-PrNML
005      
20220506130550.0
007      
ta
008      
220425s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/pros.24224 $2 doi
035    __
$a (PubMed)34516668
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Wenzel, Mike $u Department of Urology, University Hospital Frankfurt, Frankfurt am Main, Frankfurt, Germany $u Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Canada $1 https://orcid.org/0000000243380889
245    10
$a Increased risk of postoperative in-hospital complications after radical prostatectomy in patients with prior organ transplant / $c M. Wenzel, C. Würnschimmel, F. Chierigo, Z. Tian, SF. Shariat, C. Terrone, F. Saad, D. Tilki, M. Graefen, S. Banek, LA. Kluth, P. Mandel, FKH. Chun, PI. Karakiewicz
520    9_
$a BACKGROUND: To analyze postoperative, in-hospital, complication rates in patients with organ transplantation before radical prostatectomy (RP). METHODS: From National Inpatient Sample (NIS) database (2000-2015) prostate cancer patients treated with RP were abstracted and stratified according to prior organ transplant versus nontransplant. Multivariable logistic regression models predicted in-hospital complications. RESULTS: Of all eligible 202,419 RP patients, 216 (0.1%) underwent RP after prior organ transplantation. Transplant RP patients exhibited higher proportions of Charlson comorbidity index ≥2 (13.0% vs. 3.0%), obesity (9.3% vs. 5.6%, both p < 0.05), versus to nontransplant RP. Of transplant RP patients, 96 underwent kidney (44.4%), 44 heart (20.4%), 40 liver (18.5%), 30 (13.9%) bone marrow, <11 lung (<5%), and <11 pancreatic (<5%) transplantation before RP. Within transplant RP patients, rates of lymph node dissection ranged from 37.5% (kidney transplant) to 60.0% (bone marrow transplant, p < 0.01) versus 51% in nontransplant patients. Regarding in-hospital complications, transplant patients more frequently exhibited, diabetic (31.5% vs. 11.6%, p < 0.001), major (7.9% vs. 2.9%) cardiac complications (3.2% vs. 1.2%, p = 0.01), and acute kidney failure (5.1% vs. 0.9%, p < 0.001), versus nontransplant RP. In multivariable logistic regression models, transplant RP patients were at higher risk of acute kidney failure (odds ratio [OR]: 4.83), diabetic (OR: 2.81), major (OR: 2.39), intraoperative (OR: 2.38), cardiac (OR: 2.16), transfusion (OR: 1.37), and overall complications (1.36, all p < 0.001). No in-hospital mortalities were recorded in transplant patients after RP. CONCLUSIONS: Of all transplants before RP, kidney ranks first. RP patients with prior transplantation have an increased risk of in-hospital complications. The highest risk, relative to nontransplant RP patients appears to acute kidney failure.
650    12
$a akutní poškození ledvin $x epidemiologie $x etiologie $x terapie $7 D058186
650    _2
$a komorbidita $7 D015897
650    _2
$a databáze faktografické $7 D016208
650    _2
$a transplantace srdce $x statistika a číselné údaje $7 D016027
650    _2
$a hospitalizace $x statistika a číselné údaje $7 D006760
650    _2
$a lidé $7 D006801
650    _2
$a transplantace ledvin $x statistika a číselné údaje $7 D016030
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a transplantace orgánů $x klasifikace $x statistika a číselné údaje $7 D016377
650    12
$a pooperační komplikace $x diagnóza $x epidemiologie $x terapie $7 D011183
650    _2
$a prostatektomie $x škodlivé účinky $x metody $x statistika a číselné údaje $7 D011468
650    12
$a nádory prostaty $x epidemiologie $x patologie $x chirurgie $7 D011471
650    _2
$a hodnocení rizik $x statistika a číselné údaje $7 D018570
650    _2
$a rizikové faktory $7 D012307
651    _2
$a Německo $x epidemiologie $7 D005858
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Würnschimmel, Christoph $u Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Canada $u Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany $1 https://orcid.org/0000000178914791
700    1_
$a Chierigo, Francesco $u Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Canada $u Department of Urology, Policlinico San Martino Hospital, University of Genova, Genova, Italy
700    1_
$a Tian, Zhe $u Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Canada
700    1_
$a Shariat, Shahrokh F $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria $u Departments of Urology, Weill Cornell Medical College, New York, New York, USA $u Department of Urology, University of Texas Southwestern, Dallas, Texas, USA $u Department of Urology, Second Faculty of Medicine, Charles University, Prag, Czech Republic $u Institute for Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia $u Division of Urology, Department of Special Surgery, Jordan University Hospital, The University of Jordan, Amman, Jordan
700    1_
$a Terrone, Carlo $u Department of Urology, Policlinico San Martino Hospital, University of Genova, Genova, Italy
700    1_
$a Saad, Fred $u Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Canada
700    1_
$a Tilki, Derya $u Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany $u Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany $1 https://orcid.org/0000000170331380
700    1_
$a Graefen, Markus $u Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany
700    1_
$a Banek, Severiné $u Department of Urology, University Hospital Frankfurt, Frankfurt am Main, Frankfurt, Germany
700    1_
$a Kluth, Luis A $u Department of Urology, University Hospital Frankfurt, Frankfurt am Main, Frankfurt, Germany
700    1_
$a Mandel, Philipp $u Department of Urology, University Hospital Frankfurt, Frankfurt am Main, Frankfurt, Germany
700    1_
$a Chun, Felix K H $u Department of Urology, University Hospital Frankfurt, Frankfurt am Main, Frankfurt, Germany
700    1_
$a Karakiewicz, Pierre I $u Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Canada
773    0_
$w MED00010484 $t The Prostate $x 1097-0045 $g Roč. 81, č. 16 (2021), s. 1294-1302
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34516668 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506130542 $b ABA008
999    __
$a ok $b bmc $g 1789454 $s 1163064
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 81 $c 16 $d 1294-1302 $e 20210913 $i 1097-0045 $m The Prostate $n Prostate $x MED00010484
LZP    __
$a Pubmed-20220425
Back

Find record

Citation metrics

Archiving options